Bandarenko, N., Zakarija, A., Kim, B., Kwaan, H. C., Mckoy, J. M., Pandey, D. K., … Winters, J. L. (2006). Two mechanistic pathways of ticlopidine- and Clopidogrel-Associated TTP: Results from the surveillance, epidemiology, and risk factors for TTP (SERF-TTP) research. In TRANSFUSION (Vol. 46, pp. 29A-29A). Miami Beach, FL: WILEY.

Bandarenko, N., A. Zakarija, B. Kim, H. C. Kwaan, J. M. Mckoy, D. K. Pandey, S. N. Hay, et al. “Two mechanistic pathways of ticlopidine- and Clopidogrel-Associated TTP: Results from the surveillance, epidemiology, and risk factors for TTP (SERF-TTP) research.” In TRANSFUSION, 46:29A-29A. WILEY, 2006.

Bandarenko N, Zakarija A, Kim B, Kwaan HC, Mckoy JM, Pandey DK, et al. Two mechanistic pathways of ticlopidine- and Clopidogrel-Associated TTP: Results from the surveillance, epidemiology, and risk factors for TTP (SERF-TTP) research. In: TRANSFUSION. WILEY; 2006. p. 29A-29A.

Bandarenko, N., et al. “Two mechanistic pathways of ticlopidine- and Clopidogrel-Associated TTP: Results from the surveillance, epidemiology, and risk factors for TTP (SERF-TTP) research.” TRANSFUSION, vol. 46, no. 9, WILEY, 2006, pp. 29A-29A.

Bandarenko N, Zakarija A, Kim B, Kwaan HC, Mckoy JM, Pandey DK, Hay SN, Sarode R, Tevar AD, Cursio JF, Raife TJ, Kiss JE, Davidson C, Sadler JE, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y, Bennett CL, Winters JL. Two mechanistic pathways of ticlopidine- and Clopidogrel-Associated TTP: Results from the surveillance, epidemiology, and risk factors for TTP (SERF-TTP) research. TRANSFUSION. WILEY; 2006. p. 29A-29A.